HEAD & NECK CANCERS

Latest News

FDA Grants Priority Review to NDA of Avasopasem for RT-Induced Severe Oral Mucositis
FDA Grants Priority Review to NDA of Avasopasem for RT-Induced Severe Oral Mucositis

February 20th 2023

Based on findings from the phase 2b GT-201 and phase 3 ROMAN trials, the FDA has granted priority review to the new drug application for avasopasem manganese as a treatment for radiotherapy-induced severe oral mucositis in patients with head and neck cancer.

Precision Oncology Inches into Head and Neck Cancer Paradigm
Precision Oncology Inches into Head and Neck Cancer Paradigm

February 4th 2023

FDA Decision on Toripalimab for Advanced Nasopharyngeal Carcinoma Pending Due COVID-19 Travel Restrictions
FDA Decision on Toripalimab for Advanced Nasopharyngeal Carcinoma Pending Due COVID-19 Travel Restrictions

December 24th 2022

Evaluating the Incidence of HPV-Positive/-Negative, According to NCCN Guidelines
Evaluating the Incidence of HPV-Positive/-Negative, According to NCCN Guidelines

December 23rd 2022

Racial Disparities Flood the Esophageal Cancer Space
Racial Disparities Flood the Esophageal Cancer Space

December 22nd 2022

Video Series
Video Interviews

More News